Theseus Pharmaceuticals, Inc.

Amendment
CIK: 0001745020·Pharmaceuticals·DELAWARE·Filed: Feb 4, 2021
Total Offering

$22,136,987

Amount Sold

$22,136,987

Investors

3

First Sale

Jun 14, 2018

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2017
Non-Accredited Investors
No

Related Persons

NameRole
Iain Dukes
Related Person
William C. Shakespeare
Related Person
Carl Gordon
Related Person
Michael Rome
Related Person

Company

Theseus Pharmaceuticals, Inc.

210 Broadway, Suite 201

Cambridge, MA, 02139

2127396493

SEC Filing

0001745020-21-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Theseus Pharmaceuticals, Inc. Form D Filing — $22,136,987 | FilingFlow